Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study)

• Main Authors: Smith Gillian E, Neal Keith R, Evans Meirion R, Cowden John M, Adak Goutam K, Letley Louise H, McLauchlin Jim, Tompkins David S, Bolton Frederick J, Gray James J, Hunter Paul R, Rait Greta, O'Brien Sarah J, Smyth Brian, Tam Clarence C, Rodrigues Laura C
• Format: Article
• Language: English
• Published: BMC 2010-05-01
• Series: BMC Medical Research Methodology
• Online Access: http://www.biomedcentral.com/1471-2288/10/39

<p>Abstract</p> <p>Background</p> <p>Infectious intestinal disease (IID), usually presenting as diarrhoea and vomiting, is frequently preventable. Though often mild and self-limiting, its commonness makes IID an important public health problem. In the mid 1990s around 1 in 5 people in England suffered from IID a year, costing around £0.75 billion. No routine information source describes the UK's current community burden of IID. We present here the methods for a study to determine rates and aetiology of IID in the community, presenting to primary care and recorded in national surveillance statistics. We will also outline methods to determine whether or not incidence has declined since the mid-1990s.</p> <p>Methods/design</p> <p>The Second Study of Infectious Intestinal Disease in the Community (IID2 Study) comprises several separate but related studies. We use two methods to describe IID burden in the community - a retrospective telephone survey of self-reported illness and a prospective, all-age, population-based cohort study with weekly follow-up over a calendar year. Results from the two methods will be compared. To determine IID burden presenting to primary care we perform a prospective study of people presenting to their General Practitioner with symptoms of IID, in which we intervene in clinical and laboratory practice, and an audit of routine clinical and laboratory practice in primary care. We determine aetiology of IID using molecular methods for a wide range of gastrointestinal pathogens, in addition to conventional diagnostic microbiological techniques, and characterise isolates further through reference typing. Finally, we combine all our results to calibrate national surveillance data.</p> <p>Discussion</p> <p>Researchers disagree about the best method(s) to ascertain disease burden. Our study will allow an evaluation of methods to determine the community burden of IID by comparing the different approaches to estimate IID incidence in its linked components.</p>